Market Cap: $750.32M
GI
Gyre Therapeutics, Inc.
GYRE
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $750.32M
Analysts estimated GYRE earnings of $-0.09 per share this quarter (Q2). GYRE's actual earnings were $-0.12 per share.
GYRE EPS surprise of -30.72%Analysts estimated GYRE earnings of $-0.07 per share this quarter (Q1). GYRE's actual earnings were $-0.04 per share.
GYRE EPS surprise of 39.84%Analysts estimated GYRE earnings of $0.06 per share this quarter (Q4). GYRE's actual earnings were $0.05 per share.
GYRE EPS surprise of 15.60%Analysts estimated GYRE earnings of $0.03 per share this quarter (Q3). GYRE's actual earnings were $0.08 per share.
GYRE EPS surprise of 194.12%Analysts estimated GYRE earnings of $0.03 per share this quarter (Q2). GYRE's actual earnings were $0.02 per share.
GYRE EPS surprise of 53.00%Analysts estimated GYRE earnings of $0.04 per share this quarter (Q4). GYRE's actual earnings were $-0.00 per share.
GYRE EPS surprise of -3647.83%Analysts estimated GYRE earnings of $-0.77 per share this quarter (Q3). GYRE's actual earnings were $-1.05 per share.
GYRE EPS surprise of -37.25%